-
EP1856074
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1856074
| EP1856074 - SUBSTITUTED ARYL OR HETEROARYLSULFONYLBUTANAMIDES FOR USE AS ANTI-INFLAMMATORY AGENTS [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 30.04.2010 Database last updated on 13.11.2024 | Most recent event Tooltip | 30.04.2010 | Withdrawal of application | published on 02.06.2010 [2010/22] | Applicant(s) | For all designated states Amgen, Inc One Amgen Center Drive Thousand Oaks CA 91320 / US | [2007/47] | Inventor(s) | 01 /
ASKEW, Ben, C., Jr. 266 Arrowhead Road Marshfield, Massachusetts 02050 / US | 02 /
AYA, Toshihiro 899 St. Charles Drive, Apt No.1 Thousand Oaks, California 91360 / US | 03 /
BISWAS, Kaustav 26003 Alizia Canyon Drive, Unit B Calabasas, California 91302 / US | 04 /
CHEN, Jian J. 677 Via Carro Newbury Park, California 91320 / US | 05 /
HUMAN, Jason Brooks 2021 Brownstone Court Gastonia, NC 28054 / US | 06 /
QIAN, Wenyuan 2548 Villamonte Court Camarillo, California 93010 / US | [2007/47] | Representative(s) | Siegert, Georg Hoffmann - Eitle ATTENTION : ADDRESS INACTIVE - USE ASS-NR - CDR / DE | [N/P] |
| Former [2007/47] | Siegert, Georg Hoffmann - Eitle Patent- und Rechtsanwälte Arabellastrasse 4 81925 München / DE | Application number, filing date | 05802041.3 | 05.10.2005 | [2007/47] | WO2005US35767 | Priority number, date | US20040616685P | 06.10.2004 Original published format: US 616685 P | [2007/47] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2006041888 | Date: | 20.04.2006 | Language: | EN | [2006/16] | Type: | A2 Application without search report | No.: | EP1856074 | Date: | 21.11.2007 | Language: | EN | The application published by WIPO in one of the EPO official languages on 20.04.2006 takes the place of the publication of the European patent application. | [2007/47] | Search report(s) | International search report - published on: | EP | 07.09.2007 | Classification | IPC: | C07D295/12, C07D311/68, C07D401/04, C07D233/26, C07C317/50, A61K31/4453, A61K31/353, A61K31/4164, A61K31/4409, A61K31/165, A61P29/00 | [2007/47] | CPC: |
C07D295/135 (EP,US);
A61P29/00 (EP);
C07C317/46 (EP,US);
C07D233/26 (EP,US);
C07D311/68 (EP,US);
C07D401/04 (EP,US);
C07C2602/10 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/47] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | YU | Not yet paid | Title | German: | SUBSTITUIERTE ARYL- ODER HETEROARYLSULFONYLBUTANAMIDE ZUR VERWENDUNG ALS ENTZÜNDUNGSHEMMENDE WIRKSTOFFE | [2007/47] | English: | SUBSTITUTED ARYL OR HETEROARYLSULFONYLBUTANAMIDES FOR USE AS ANTI-INFLAMMATORY AGENTS | [2007/47] | French: | ARYL OU HETEROARYLSULFONYLBUTANAMIDES SUBSTITUES ET LEUR METHODES D'UTILISATION | [2007/47] | Entry into regional phase | 04.04.2007 | National basic fee paid | 04.04.2007 | Designation fee(s) paid | 04.04.2007 | Examination fee paid | Examination procedure | 04.04.2007 | Examination requested [2007/47] | 28.04.2010 | Application withdrawn by applicant [2010/22] | Fees paid | Renewal fee | 12.10.2007 | Renewal fee patent year 03 | 31.03.2008 | Renewal fee patent year 04 | 13.10.2009 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]EP1302462 (TAKEDA CHEMICAL INDUSTRIES LTD [JP]) [X] 1-5,23-25 * see examples 30, 58, 62 and 126 and their antiinflammmatory activity *; | [YX]EP1389616 (MITSUBISHI PHARMA CORP [JP]) [Y] 1-25 * see e.g. starting material for example 4 on p. 26 and example 4 on p. 41 and its antiinflammatory activity * [X] 21-25; | [Y]US6306873 (BURNS CHRISTOPHER J [US], et al) [Y] 1-25 * see e.g. the butyramide of claim 24, column 54, 50-51 and its use in inflammatory diseases * |